Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VISIODOL: Validation of the VISIODOL® Scale for Screening of Pain in People With Visual Impairment

NCT03968991 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT03968991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03968991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VISIODOL: Validation of the VISIODOL® Scale for Screening of Pain in People With Visual Impairment
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Terminated
Start date
June 18, 2019
Completion date
December 28, 2020
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired blindness, congenital blindness, visual deficiency